## Abstract ## BACKGROUND To the authors' knowledge, little is known to date regarding the prognostic relevance of measuring serum levels of vascular endothelial growth factor (VEGF), a potent stimulator of angiogenesis, in patients with colon carcinoma who undergo surgery. ## METHODS Preoperati
Increased Serum Levels of Vascular Endothelial Growth Factor in Patients with Renal Cell Carcinoma
โ Scribed by Sato, Kazunari ;Tsuchiya, Norihiko ;Sasaki, Ryusei ;Shimoda, Naotake ;Satoh, Shigeru ;Ogawa, Osamu ;Kato, Tetsuro
- Book ID
- 108581799
- Publisher
- Wiley (Blackwell Publishing)
- Year
- 1999
- Tongue
- English
- Weight
- 90 KB
- Volume
- 90
- Category
- Article
- ISSN
- 0910-5050
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
I read with interest the article by Kettritz et al. 1 regarding the accuracy of stereotactic 11-gauge vacuum-assisted breast biopsy (VAB) for diagnosing breast cancer in nonpalpable breast lesions. Of the 2893 VAB procedures performed, 19 (0.7%) yielded findings that were not representative, whereas
It is known that vascular endothelial growth factor (VEGF) family is an important role in vasculogenesis and angiogenesis. Among the VEGF family members, VEGF-A plays an essential role in angiogenesis. However, the significance of serum levels of other VEGF members (VEGF-C and -D) has been reported